Clinical outcomes in pediatric hydrocephalus patients treated with endoscopic third ventriculostomy and choroid plexus cauterization: a systematic review and meta-analysis.

4区 医学 Q1 Medicine Atherosclerosis. Supplements Pub Date : 2022-05-06 Print Date: 2022-07-01 DOI:10.3171/2022.3.PEDS21512
David Ben-Israel, Jennifer A Mann, Michael M H Yang, Albert M Isaacs, Magalie Cadieux, Nicholas Sader, Sandeep Muram, Abdulrahman Albakr, Branavan Manoranjan, Richard W Yu, Benjamin Beland, Mark G Hamilton, Eldon Spackman, Paul E Ronksley, Jay Riva-Cambrin
{"title":"Clinical outcomes in pediatric hydrocephalus patients treated with endoscopic third ventriculostomy and choroid plexus cauterization: a systematic review and meta-analysis.","authors":"David Ben-Israel, Jennifer A Mann, Michael M H Yang, Albert M Isaacs, Magalie Cadieux, Nicholas Sader, Sandeep Muram, Abdulrahman Albakr, Branavan Manoranjan, Richard W Yu, Benjamin Beland, Mark G Hamilton, Eldon Spackman, Paul E Ronksley, Jay Riva-Cambrin","doi":"10.3171/2022.3.PEDS21512","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Endoscopic third ventriculostomy and choroid plexus cauterization (ETV+CPC) is a novel procedure for infant hydrocephalus that was developed in sub-Saharan Africa to mitigate the risks associated with permanent implanted shunt hardware. This study summarizes the hydrocephalus literature surrounding the ETV+CPC intraoperative abandonment rate, perioperative mortality rate, cerebrospinal fluid infection rate, and failure rate.</p><p><strong>Methods: </strong>This systematic review and meta-analysis followed a prespecified protocol and abides by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive search strategy using MEDLINE, EMBASE, PsychInfo, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Scopus, and Web of Science was conducted from database inception to October 2019. Studies included controlled trials, cohort studies, and case-control studies of patients with hydrocephalus younger than 18 years of age treated with ETV+CPC. Pooled estimates were calculated using DerSimonian and Laird random-effects modeling, and the significance of subgroup analyses was tested using meta-regression. The quality of the pooled outcomes was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.</p><p><strong>Results: </strong>After screening and reviewing 12,321 citations, the authors found 16 articles that met the inclusion criteria. The pooled estimate for the ETV+CPC failure rate was 0.44 (95% CI 0.37-0.51). Subgroup analysis by geographic income level showed statistical significance (p < 0.01), with lower-middle-income countries having a lower failure rate (0.32, 95% CI 0.28-0.36) than high-income countries (0.53, 95% CI 0.47-0.60). No difference in failure rate was found between hydrocephalus etiology (p = 0.09) or definition of failure (p = 0.24). The pooled estimate for perioperative mortality rate (n = 7 studies) was 0.001 (95% CI 0.00-0.004), the intraoperative abandonment rate (n = 5 studies) was 0.04 (95% CI 0.01-0.08), and the postoperative CSF infection rate (n = 5 studies) was 0.0004 (95% CI 0.00-0.003). All pooled outcomes were found to be low-quality evidence.</p><p><strong>Conclusions: </strong>This systematic review and meta-analysis provides the most comprehensive pooled estimate for the ETV+CPC failure rate to date and demonstrates, for the first time, a statistically significant difference in failure rate by geographic income level. It also provides the first reported pooled estimates for the risk of ETV+CPC perioperative mortality, intraoperative abandonment, and CSF infection. The low quality of this evidence highlights the need for further research to improve the understanding of these critical clinical outcomes and their relevant explanatory variables and thus to appreciate which patients may benefit most from an ETV+CPC. Systematic review registration no.: CRD42020160149 (https://www.crd.york.ac.uk/prospero/).</p>","PeriodicalId":8592,"journal":{"name":"Atherosclerosis. Supplements","volume":"6 1","pages":"18-30"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Atherosclerosis. Supplements","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3171/2022.3.PEDS21512","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/1 0:00:00","PubModel":"Print","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Endoscopic third ventriculostomy and choroid plexus cauterization (ETV+CPC) is a novel procedure for infant hydrocephalus that was developed in sub-Saharan Africa to mitigate the risks associated with permanent implanted shunt hardware. This study summarizes the hydrocephalus literature surrounding the ETV+CPC intraoperative abandonment rate, perioperative mortality rate, cerebrospinal fluid infection rate, and failure rate.

Methods: This systematic review and meta-analysis followed a prespecified protocol and abides by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive search strategy using MEDLINE, EMBASE, PsychInfo, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Scopus, and Web of Science was conducted from database inception to October 2019. Studies included controlled trials, cohort studies, and case-control studies of patients with hydrocephalus younger than 18 years of age treated with ETV+CPC. Pooled estimates were calculated using DerSimonian and Laird random-effects modeling, and the significance of subgroup analyses was tested using meta-regression. The quality of the pooled outcomes was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.

Results: After screening and reviewing 12,321 citations, the authors found 16 articles that met the inclusion criteria. The pooled estimate for the ETV+CPC failure rate was 0.44 (95% CI 0.37-0.51). Subgroup analysis by geographic income level showed statistical significance (p < 0.01), with lower-middle-income countries having a lower failure rate (0.32, 95% CI 0.28-0.36) than high-income countries (0.53, 95% CI 0.47-0.60). No difference in failure rate was found between hydrocephalus etiology (p = 0.09) or definition of failure (p = 0.24). The pooled estimate for perioperative mortality rate (n = 7 studies) was 0.001 (95% CI 0.00-0.004), the intraoperative abandonment rate (n = 5 studies) was 0.04 (95% CI 0.01-0.08), and the postoperative CSF infection rate (n = 5 studies) was 0.0004 (95% CI 0.00-0.003). All pooled outcomes were found to be low-quality evidence.

Conclusions: This systematic review and meta-analysis provides the most comprehensive pooled estimate for the ETV+CPC failure rate to date and demonstrates, for the first time, a statistically significant difference in failure rate by geographic income level. It also provides the first reported pooled estimates for the risk of ETV+CPC perioperative mortality, intraoperative abandonment, and CSF infection. The low quality of this evidence highlights the need for further research to improve the understanding of these critical clinical outcomes and their relevant explanatory variables and thus to appreciate which patients may benefit most from an ETV+CPC. Systematic review registration no.: CRD42020160149 (https://www.crd.york.ac.uk/prospero/).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
采用内窥镜第三脑室造口术和脉络丛烧灼术治疗小儿脑积水患者的临床疗效:系统回顾和荟萃分析。
目的:内镜下第三脑室造口术和脉络丛烧灼术(ETV+CPC)是一种治疗婴儿脑积水的新型手术,该手术在撒哈拉以南非洲地区开展,旨在降低与永久性植入分流硬件相关的风险。本研究总结了围绕 ETV+CPC 术中放弃率、围手术期死亡率、脑脊液感染率和失败率的脑积水文献:本系统综述和荟萃分析遵循预先指定的方案,并遵守系统综述和荟萃分析首选报告项目(PRISMA)指南。从数据库建立到 2019 年 10 月,我们使用 MEDLINE、EMBASE、PsychInfo、Cochrane Central Register of Controlled Trials、Cochrane Database of Systematic Reviews、Scopus 和 Web of Science 进行了全面检索。研究内容包括采用 ETV+CPC 治疗 18 岁以下脑积水患者的对照试验、队列研究和病例对照研究。使用 DerSimonian 和 Laird 随机效应模型计算汇总估计值,并使用元回归检验亚组分析的显著性。采用建议评估、发展和评价分级(GRADE)方法对汇总结果的质量进行了评估:在筛选和审查了 12,321 篇引文后,作者发现有 16 篇文章符合纳入标准。ETV+CPC失败率的汇总估计值为0.44(95% CI 0.37-0.51)。按地域收入水平进行的分组分析显示出统计学意义(P < 0.01),中低收入国家的失败率(0.32,95% CI 0.28-0.36)低于高收入国家(0.53,95% CI 0.47-0.60)。不同脑积水病因(P = 0.09)或不同失败定义(P = 0.24)之间的失败率没有差异。围手术期死亡率(n = 7 项研究)的汇总估计值为 0.001(95% CI 0.00-0.004),术中放弃率(n = 5 项研究)为 0.04(95% CI 0.01-0.08),术后 CSF 感染率(n = 5 项研究)为 0.0004(95% CI 0.00-0.003)。所有汇总结果均为低质量证据:这项系统回顾和荟萃分析提供了迄今为止最全面的 ETV+CPC 失败率汇总估计值,并首次证明了不同地域收入水平的失败率存在显著的统计学差异。它还首次报告了 ETV+CPC 围手术期死亡率、术中放弃和 CSF 感染风险的汇总估计值。这些证据的质量不高,突出表明需要进一步研究,以加深对这些关键临床结果及其相关解释变量的理解,从而了解哪些患者可能从 ETV+CPC 中获益最多。系统综述注册编号:CRD42020160149 (https://www.crd.york.ac.uk/prospero/)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Atherosclerosis. Supplements
Atherosclerosis. Supplements 医学-外周血管病
CiteScore
4.80
自引率
0.00%
发文量
0
审稿时长
>12 weeks
期刊介绍: Atherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations.
期刊最新文献
Historical and pathological overview of Castleman disease. Clinical outcomes in pediatric hydrocephalus patients treated with endoscopic third ventriculostomy and choroid plexus cauterization: a systematic review and meta-analysis. Smoker characteristics and trends in tobacco smoking in Rakai, Uganda, 2010-2018. A Potential Nutritional Indicator Predictable for Stroke-Related Sarcopenia. CORRIGENDUM: Outcomes of Dilated Cardiomyopathy in Japanese Children - A Retrospective Cohort Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1